Merck & Co IncMRK
Price$143.81Intrinsic value$70.1851% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $70.18median of 6 methods · middle span $28-$109based on filings through 30 Jun 2026
Market Price $143.81Price as of 1 Oct 2026
Margin of Safety -51.2%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 0.7% (near-term consensus, capped) · years 2–5: 6.6%/yr (balance of the path).5.4% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 66.4%Yr 76.2%Yr 85.9%Yr 95.7%Yr 105.4%
6.6% → 5.4%
Years 11–20: glide to long-run rate
Per-year rates
Yr 115.2%Yr 125.0%Yr 134.7%Yr 144.5%Yr 154.2%Yr 164.0%Yr 173.7%Yr 183.5%Yr 193.2%Yr 203.0%
5.4% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)17.8%
Discount rate (cost of equity) 7.0%
Volatility vs market (adjusted beta)0.46

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetMerck & Co IncMRKHealth Care
Valuation
P/E115.0×
P/S5.5×
P/B8.6×
EV / Revenue6.2×
EV / EBITDA—
Profitability
Gross margin—
Operating margin8.9%
Net margin4.8%
FCF margin24.1%
Returns
ROE7.6%
ROA2.4%
ROIC3.6%
Growth
Revenue growth (YoY)3.7%
5-yr fwd EPS growth5.4%
Financial strength
Debt / Equity1.27×
Current ratio1.32×
Altman Z-Score4.0
Interest coverage—
Dividend yield1.1%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.